Trial Profile
Evaluating N-acetylcysteine efficacy in the prevention of amphotericin B-induced nephrotoxicity -
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Oct 2015
Price :
$35
*
At a glance
- Drugs Acetylcysteine (Primary)
- Indications Acute kidney injury; Mycoses
- Focus Adverse reactions
- 15 Oct 2015 New trial record